AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same

Reuters) – AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by U.S. regulators, and an oversight panel has recommended that Johnson & Johnson resume its trial as well, the companies said on Friday.

AstraZeneca’s U.S. trial was paused on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company’s UK trial.

U.S. Health and Human Services Deputy Chief of Staff Paul Mango also told reporters he was optimistic a U.S. trial by J&J would resume.

J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating.

AstraZeneca trials in the United Kingdom, Brazil and South Africa resumed last month even as the U.S. Food and Drug Administration continued its investigation into the case.Read More.

http://AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.